SVP F&A, CFO, Treas & Asst Sec of Regeneron Pharmaceuticals Inc. (REGN, Financial) Murray A Goldberg sells 6,100 shares of REGN on 06/04/2010 at an average price of $28.88 a share.
Regeneron Pharmaceuticals Inc. has a market cap of $2.3 billion; its shares were traded at around $28.19 with and P/S ratio of 6.07.
REGN is in the portfolios of Carl Icahn of Icahn Capital Management LP, Chuck Royce of Royce& Associates.
Regeneron Pharmaceuticals Inc. has a market cap of $2.3 billion; its shares were traded at around $28.19 with and P/S ratio of 6.07.
REGN is in the portfolios of Carl Icahn of Icahn Capital Management LP, Chuck Royce of Royce& Associates.
CFO Recent Trades:
- Sell:: SVP F&A, CFO, Treas & Asst Sec Murray A Goldberg sold 6,105 shares of REGN stock on 02/04/2010 at the average price of 27.09, the price of the stock has increased by 4.06% since.
- Sell:: SVP F&A, CFO, Treas & Asst Sec Murray A Goldberg sold 12,708 shares of REGN stock on 01/06/2010 at the average price of 24.88, the price of the stock has increased by 13.3% since.
Directors and Officers Recent Trades:
- Buy:: Director George L Sing bought 7,500 shares of REGN stock on 05/18/2010 at the average price of 28.51, the price of the stock has decreased by 1.12% since.
- Sell:: Director Michael S Brown sold 524 shares of REGN stock on 05/19/2010 at the average price of 27.73, the price of the stock has increased by 1.66% since.
- Sell:: Director Joseph L Goldstein sold 400 shares of REGN stock on 05/17/2010 at the average price of 28.06, the price of the stock has increased by 0.46% since.
- Sell:: Director P Roy Vagelos sold 20,000 shares of REGN stock on 05/14/2010 at the average price of 27.16, the price of the stock has increased by 3.79% since.
- Sell:: Director Eric M Shooter sold 15,000 shares of REGN stock on 02/17/2010 at the average price of 30, the price of the stock has decreased by 6.03% since.
